Animal Vaccine Market

Market Overview: 

The global animal vaccine market size reached US$ 12.38 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 19.88 Billion by 2028, exhibiting a growth rate (CAGR) of 8.04% during 2023-2028. The increasing demand for animal-derived products, the rise in zoonotic diseases, growing pet ownership, significant advancements in biotechnology, and favorable government initiatives promoting animal health. are some of the major factors propelling the market.

An animal vaccine is a biological substance designed to stimulate an immune response in animals, providing protection against specific infectious diseases. Similar to human vaccines, animal vaccines contain antigens derived from the disease-causing agent or a related organism. When administered, the vaccine stimulates the animal's immune system to produce an immune response, including the production of antibodies and memory cells. This immune response prepares the animal's body to recognize and defend against future infections by the target pathogen. Animal vaccines play a crucial role in preventing the spread of infectious diseases among livestock, pets, and wildlife, thus contributing to the overall health and well-being of animals and humans alike.

The increasing global demand for animal-derived products, such as meat, milk, and eggs, has led to a greater emphasis on maintaining the health and productivity of livestock. Vaccines play a vital role in preventing and controlling infectious diseases in animals, ensuring a consistent and safe food supply. Additionally, the rise in zoonotic diseases, which are infections that can be transmitted between animals and humans, has increased awareness about the importance of vaccinating animals to prevent the spread of diseases that can have significant public health implications. Besides this, the growing pet ownership and increasing concern for their well-being have fueled the demand for vaccines. Moreover, advancements in biotechnology and genetic engineering have enabled the development of more effective and targeted vaccines, enhancing their efficacy and safety. These factors, along with the implementation of government initiatives and regulations promoting animal health, have contributed to the expansion of the animal vaccine market.

Animal Vaccine Market Trends/Drivers:

Increasing global demand for animal-derived products

The global demand for animal-derived products such as meat, milk, and eggs has witnessed a significant surge in recent years. With the growing population and changing dietary preferences, there is a higher need for sustainable and safe food sources. Vaccines play a crucial role in maintaining the health and productivity of livestock. By preventing and controlling infectious diseases, vaccines ensure that animals remain healthy and free from diseases that can impact their growth, reproduction, and overall well-being. This, in turn, leads to a consistent and safe food supply for consumers. As a result, the increasing global demand for animal-derived products acts as a strong driving force for the animal vaccine market.

Rise in zoonotic diseases

Zoonotic diseases are infections that can be transmitted between animals and humans, such as avian influenza, rabies, and brucellosis. These diseases pose a threat to animal health and also have significant public health implications. Vaccinating animals against zoonotic diseases is crucial in preventing their transmission to humans. The COVID-19 pandemic, caused by the zoonotic SARS-CoV-2 virus, has further highlighted the importance of preventing and controlling such diseases through animal vaccination. The increasing awareness of zoonotic diseases and their potential impact on human health has resulted in a higher demand for animal vaccines as a preventive measure.

Growing pet ownership and concern for companion animal health

Pet ownership has been on the rise globally, with more people considering pets as family members and companions. This growing trend has led to an increased focus on the health and well-being of companion animals, including dogs, cats, and horses. Vaccinating pets is crucial for preventing infectious diseases that can affect their health and longevity. Pet owners are increasingly aware of the benefits of vaccination in protecting their beloved animals from common and potentially severe diseases. Additionally, stricter regulations and requirements for pet vaccinations, such as those related to boarding, travel, and licensing, have further contributed to the market growth. The growing concern for companion animal health and the desire to provide them with the best care have fueled the growth of the animal vaccine market in this particular area.

Animal Vaccine Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global animal vaccine market report, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on product, animal type, route of administration.

Breakup by Product:

• Attenuated vaccines
• Inactivated vaccines
• Subunit vaccines
• Toxoid vaccines
• Conjugate vaccines
• Recombinant vaccines
• DNA vaccines Type
   

Attenuated vaccines represent the most popular animal vaccines

The report has provided a detailed breakup and analysis of the market based on the product. This includes attenuated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, conjugate vaccines, recombinant vaccines, and DNA vaccines. According to the report, attenuated vaccines represented the largest segment.

Attenuated vaccines, which are created from weakened forms of pathogens, are playing a significant role in driving the market. These vaccines are designed to stimulate a strong immune response in animals while posing minimal risk of causing disease. Attenuated vaccines offer several advantages, including long-lasting protection, single-dose administration, and cost-effectiveness. Their efficacy in preventing infectious diseases in animals has led to increased adoption by veterinarians and livestock producers. The growing demand for livestock products, rising awareness about zoonotic diseases, and the need to ensure animal health and welfare are key factors contributing to the expansion of the animal vaccines market, with attenuated vaccines at the forefront of this growth.

Breakup by Animal Type:

• Companion animal  
  • Dogs
  • Cats
• Livestock animal  
  • Cattle
  • Pigs
  • Poultry
  • Sheep
  • Others
• Aquaculture
   

Livestock animal hold the largest share in the market

A detailed breakup and analysis of the market based on the animal type has also been provided in the report. This includes companion animal (dogs and cats), livestock animal (cattle, pigs, poultry, sheep, and others), and aquaculture.  According to the report, livestock animal accounted for the largest market share.

The global demand for livestock products, such as meat, milk, and eggs, is steadily rising due to population growth and changing dietary preferences. To meet this demand, farmers and livestock producers are increasingly focusing on improving animal health and preventing diseases. Vaccination plays a pivotal role in achieving these goals by safeguarding animals from infectious diseases, improving their overall well-being, and enhancing productivity. As a result, the need for effective and efficient animal vaccines is escalating, thus prompting continuous research and development in this field.

Breakup by Route of Administration:

• Subcutaneous
• Intramuscular
• Intranasal
• Others
   

Subcutaneous route of administration dominates the market

The report has provided a detailed breakup and analysis of the market based on the route of administration. This includes subcutaneous, intramuscular, intranasal, and others. According to the report, subcutaneous represented the largest segment.

Subcutaneous injection is a relatively simple and safe method that can be easily performed by veterinarians or trained personnel. It is administered just beneath the skin, allowing for efficient absorption of the vaccine into the bloodstream. This route also provides a sustained release of the vaccine, leading to longer-lasting immune responses. Additionally, subcutaneous administration allows for the simultaneous administration of multiple vaccines in different locations, reducing the need for multiple injections. These factors contribute to the widespread adoption of subcutaneous administration, making it the dominant route in the animal vaccine market.

Breakup by Region:

• North America
  • United States
  • Canada
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Others
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa
   

North America exhibits a clear dominance in the market

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for animal vaccines.

The region has a significant livestock industry, including cattle, poultry, swine, and aquaculture, which requires robust vaccination programs to ensure animal health and productivity. The demand for livestock products in North America is high, driven by a growing population, increasing disposable incomes, and dietary preferences. As a result, there is a strong emphasis on preventing diseases and maintaining high-quality animal products, leading to a higher adoption of animal vaccines. Additionally, North America has a well-established veterinary healthcare system and stringent regulatory standards for animal health. This supports the development, registration, and distribution of animal vaccines, encouraging innovation and investment in the market. The presence of leading pharmaceutical companies and vaccine manufacturers in the region further boosts the availability and accessibility of animal vaccines. Other than this, the region has witnessed outbreaks of zoonotic diseases, such as avian influenza, swine flu, and bovine tuberculosis, in the past. These incidents have heightened awareness about the importance of animal vaccination in preventing the spread of diseases to humans, thus driving the demand for animal vaccines.

Competitive Landscape:

The leading companies in the market are investing heavily in research and development to introduce innovative and effective vaccines. They focus on enhancing vaccine efficacy, improving safety profiles, and expanding their product portfolios to cater to a wide range of animal species. Additionally, key players often engage in strategic partnerships and collaborations with academic institutions, research organizations, and veterinary clinics. Besides this, numerous companies are expanding their geographic presence by entering new markets and regions. Furthermore, in order to stay competitive, companies continually launch new animal vaccines and expand their product portfolios. This includes developing vaccines for emerging or neglected diseases, as well as introducing next-generation vaccines with improved characteristics such as longer duration of immunity or reduced number of doses. Moreover, effective marketing and awareness campaigns are crucial for promoting animal vaccines. Key players engage in educational initiatives targeting veterinarians, livestock producers, and pet owners to create awareness about the importance of vaccination and the benefits it provides in preventing diseases.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

• C.H. Boehringer Sohn AG & Co. KG
• Ceva Sante Animale
• Elanco Animal Health Incorporated (Eli Lilly and Company)
• Hester Biosciences Limited
• Hipra S.A.
• Hygieia Biological Laboratories
• Merck & Co. Inc.
• Phibro Animal Health Corporation
• Vaxxinova GmbH (EW Group)
• Virbae
• Zoetis Services LLC

Animal Vaccine Market Report Scope:

Report Coverage:

Key Questions Answered in This Report:

• How has the global animal vaccine market performed so far, and how will it perform in the coming years?
• What are the drivers, restraints, and opportunities in the global animal vaccine market?
• What is the impact of each driver, restraint, and opportunity on the global animal vaccine market?
• What are the key regional markets?
• Which countries represent the most attractive animal vaccine market?
• What is the breakup of the market based on the product?
• Which is the most attractive product in the animal vaccine market?
• What is the breakup of the market based on the animal type?
• Which is the most attractive animal type in the animal vaccine market?
• What is the breakup pf the market based on the route of administration?
• Which is the most attractive route of administration in the animal vaccine market?
• What is the competitive structure of the global animal vaccine market?
• Who are the key players/companies in the global animal vaccine market?

Key Benefits for Stakeholders:

• IMARC’s report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the animal vaccine market from 2017-2028.
• The research study provides the latest information on the market drivers, challenges, and opportunities in the global animal vaccine market.
• The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
• Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the animal vaccine industry and its attractiveness.
• Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.